Journal
CHANNELS
Volume 12, Issue 1, Pages 126-136Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/19336950.2018.1454814
Keywords
blood pressure; calcium-activated K+ channels; nitric oxide; endothelium; hyperpolarization; SKA-31; vasodilation
Categories
Funding
- Canadian Institutes of Health Research [MOP-97901, MOP-142467]
- Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-04116]
Ask authors/readers for more resources
Endothelial small and intermediate-conductance, Ca2+-activated K+ channels (KCa2.3 and KCa3.1, respectively) play an important role in the regulation of vascular function and systemic blood pressure. Growing evidence indicates that they are intimately involved in agonist-evoked vasodilation of small resistance arteries throughout the circulation. Small molecule activators of KCa2.x and 3.1 channels, such as SKA-31, can acutely inhibit myogenic tone in isolated resistance arteries, induce effective vasodilation in intact vascular beds, such as the coronary circulation, and acutely decrease systemic blood pressure in vivo. The blood pressure-lowering effect of SKA-31, and early indications of improvement in endothelial dysfunction suggest that endothelial KCa channel activators could eventually be developed into a new class of endothelial targeted agents to combat hypertension or atherosclerosis. This review summarises recent insights into the activation of endothelial Ca2+ activated K+ channels in various vascular beds, and how tools, such as SKA-31, may be beneficial in disease-related conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available